Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives

BACKGROUND: Previous studies and own clinical observations of patients with systemic lupus erythematosus (SLE) suggest that SLE harbors distinct immunophenotypes. This heterogeneity might result in differences in response to treatment in different subgroups and obstruct clinical trials. Our aim was...

Descripción completa

Detalles Bibliográficos
Autores principales: Idborg, Helena, Zandian, Arash, Sandberg, Ann-Sofi, Nilsson, Bo, Elvin, Kerstin, Truedsson, Lennart, Sohrabian, Azita, Rönnelid, Johan, Mo, John, Grosso, Giorgia, Kvarnström, Marika, Gunnarsson, Iva, Lehtiö, Janne, Nilsson, Peter, Svenungsson, Elisabet, Jakobsson, Per-Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378708/
https://www.ncbi.nlm.nih.gov/pubmed/30777133
http://dx.doi.org/10.1186/s13075-019-1836-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378708/
https://www.ncbi.nlm.nih.gov/pubmed/30777133
http://dx.doi.org/10.1186/s13075-019-1836-8

Ejemplares similares